TrialPathology oncology research : POR2025

Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma -the

Eyal Talor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.